COVID-19 infection may increase the risk of parkinsonism - Remember the Spanish flu?
作者信息
Eldeeb Mohamed A, Hussain Faraz S, Siddiqi Zaeem A
机构信息
Department of Neurology and Neurosurgery, Montreal Neurological Institute McGill University, Montreal, Quebec, Canada.
Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
出版信息
Cytokine Growth Factor Rev. 2020 Aug;54:6-7. doi: 10.1016/j.cytogfr.2020.06.009. Epub 2020 Jun 7.
Abstract
摘要
相似文献
1
COVID-19 infection may increase the risk of parkinsonism - Remember the Spanish flu?
Cytokine Growth Factor Rev. 2020 Aug;54:6-7. doi: 10.1016/j.cytogfr.2020.06.009. Epub 2020 Jun 7.
2
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
Cytokine Growth Factor Rev. 2020 Aug;54:62-75. doi: 10.1016/j.cytogfr.2020.06.001. Epub 2020 Jun 2.
3
Cytokine Storms: Understanding COVID-19.
Immunity. 2020 Jul 14;53(1):19-25. doi: 10.1016/j.immuni.2020.06.017. Epub 2020 Jun 28.
4
COVID-19 versus the 1918 influenza pandemic: different virus, different age mortality patterns.
J Travel Med. 2020 Aug 20;27(5). doi: 10.1093/jtm/taaa086.
5
Understanding dynamics of pandemics.
Turk J Med Sci. 2020 Apr 21;50(SI-1):515-519. doi: 10.3906/sag-2004-133.
6
Should we unstress SARS-CoV-2 infected cells?
Cytokine Growth Factor Rev. 2020 Aug;54:3-5. doi: 10.1016/j.cytogfr.2020.06.011. Epub 2020 Jun 11.
7
Comparison of Estimated Excess Deaths in New York City During the COVID-19 and 1918 Influenza Pandemics.
JAMA Netw Open. 2020 Aug 3;3(8):e2017527. doi: 10.1001/jamanetworkopen.2020.17527.
8
COVID 19 and Spanish flu pandemics: All it changes, nothing changes.
Acta Biomed. 2020 May 11;91(2):245-250. doi: 10.23750/abm.v91i2.9625.
9
[Not Available].
Rev Med Suisse. 2020 Jun 10;16(697):1222.
10
Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.
Clin Adv Hematol Oncol. 2020 Jul;18(7):400-403.
引用本文的文献
1
Virus exposure and neurodegenerative disease risk across national biobanks.
Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029. Epub 2023 Jan 19.
2
New-onset Parkinsonism as a Covid-19 infection sequela: A systematic review and meta-analysis.
Ann Med Surg (Lond). 2022 Aug;80:104281. doi: 10.1016/j.amsu.2022.104281. Epub 2022 Aug 8.
3
Parkinson's Disease in Light of the COVID-19 Pandemic.
Brain Sci. 2022 Jan 21;12(2):143. doi: 10.3390/brainsci12020143.
4
Recent Advances in Aptasensor for Cytokine Detection: A Review.
Sensors (Basel). 2021 Dec 20;21(24):8491. doi: 10.3390/s21248491.
5
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?
Brain Sci. 2021 Dec 18;11(12):1654. doi: 10.3390/brainsci11121654.
6
Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder.
J Psychiatr Res. 2022 May;149:367-373. doi: 10.1016/j.jpsychires.2021.11.025. Epub 2021 Nov 17.
7
Direct and Indirect Neurological Signs of COVID-19.
Neurosci Behav Physiol. 2021;51(7):856-866. doi: 10.1007/s11055-021-01144-9. Epub 2021 Nov 4.
8
Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson's Disease.
Front Cell Neurosci. 2021 Jun 15;15:670298. doi: 10.3389/fncel.2021.670298. eCollection 2021.
9
COVID-19, ferrosenescence and neurodegeneration, a mini-review.
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 13;109:110230. doi: 10.1016/j.pnpbp.2020.110230. Epub 2020 Dec 26.
本文引用的文献
1
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons.
Cytokine Growth Factor Rev. 2020 Jun;53:66-70. doi: 10.1016/j.cytogfr.2020.05.002. Epub 2020 May 7.
2
Nervous system involvement after infection with COVID-19 and other coronaviruses.
Brain Behav Immun. 2020 Jul;87:18-22. doi: 10.1016/j.bbi.2020.03.031. Epub 2020 Mar 30.
3
[A pathological report of three COVID-19 cases by minimal invasive autopsies].
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417. doi: 10.3760/cma.j.cn112151-20200312-00193.
4
N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
Curr Genet. 2020 Aug;66(4):693-701. doi: 10.1007/s00294-020-01062-2. Epub 2020 Mar 10.
5
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
6
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
7
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
8
A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
9
Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson's Disease.
J Parkinsons Dis. 2019;9(4):705-709. doi: 10.3233/JPD-191699.
10
The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease.
Transl Neurodegener. 2019 Aug 16;8:23. doi: 10.1186/s40035-019-0165-9. eCollection 2019.
Zotero 插件